Background Although among women a decreasing prevalence of human papillomavirus
(HPV) infection with increasing age has been consistently observed in high-resource …

Objective. To characterize the vaginal microbiome and the rate of sexually transmitted
infections (STIs) in the women of Príncipe (São Tomé and Príncipe). Methods. Cross …

Human papillomavirus (HPV) is the most common sexually transmitted infection among US
military members. The most frequent clinical manifestation of HPV is genital warts (GW). This …

This manuscript provides the available data on the burden of human papillomavirus (HPV)
infections and HPV-related diseases in Israel. The incidence of cervical intraepithelial …

Objectives Estimate the prevalence of genital warts (GW) and GW-related healthcare
resource use and costs among male and female patients seeking treatment in South Korea …

Abstract Background In the Netherlands, the HPV-vaccine uptake was 52% during the 2009
catch-up campaign (birth cohorts 1993–1996). This increased to 61% in the regular …

In order to reduce the incidence and mortality rate of cervical cancer, the World Health
Organization (WHO) declared the Global Strategy Goal for 2030, advocating for reaching a …

Abstract Background In 2009, both Norway and Denmark initiated routine quadrivalent
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …

The national cost of managing genital warts (GWs) in the UK has not been fully estimated,
yet is required to inform decisions on vaccination against human papillomavirus. This study …

Background and objective Genital warts are caused by the human papillomavirus (HPV),
whose genotypes have traditionally been classified as low risk or high risk (oncogenic). The …